Skip to main content
< Back
About
About the conference
App
Organisers & Partners
Latest updates
Press room
Registration
Call for abstracts
Programme
Tracks
Speakers
Side events
Venue
About the venue
Rooms
Subscribe
days
hours
minutes
seconds
Programme
Alcohol
Behavioural addictions
Cannabis
Capacity-building
Comorbidity
COVID-19
Crime
Criminal justice/prisons
E-health
Epidemiology
Gender issues
Harm reduction
Health consequences
Hepatitis
HIV
Infectious diseases
Markets
Medicines
Mental health
New psychoactive substances
Nicotine/tobacco
Non-substance related addictions
Overdose prevention
Policy
Prevention
Public health
Treatment
User perspectives
Vulnerable groups
Youth
WED
23 NOV
THU
24 NOV
FRI
25 NOV
Apply
Reset
For questions about the programme, please contact the
LxAddictions Abstracts Secretariat
.
Plenary session
Big debate
Structured session
Workshop
Oral presentation session
Short communication session
e-short communications
e-poster guided tour
e-posters
08:00
Arrival and registration
08:00
to
09:00
NETWORKING ZONE
08:30
Official opening
08:30
to
09:00
Main stage
João Goulão,
Alexis Goosdeel
09:00
Ensuring adequate pain relief whilst reducing addiction risk: lessons learnt and the way forward
09:00
to
10:30
Main stage
Sarah Welch
e-posters — day 1
09:00
to
19:30
Digital kiosks
e-short communications — day 1
09:00
to
19:30
Digital kiosks
10:30
Coffee break
10:30
to
10:50
10:50
Drug policy: socio-political influence, cultural diversity
10:50
to
12:20
Insights zone 1 (I1)
Abhishek Ghosh,
Dijana Jerkovic
Addressing substance use and substance use disorders in humanitarian settings: the role of evidence-based prevention, treatment and care
10:50
to
12:20
Insights zone 4 (I4)
Anja Busse
Advances in toxicology
10:50
to
12:20
Central square 2 (C2)
Ilkka Ojanperä
Commonalities across addictions
10:50
to
12:20
Insights zone 2 (I2)
Samuel Tomczyk
COVID-19 implications for services and responses
10:50
to
12:20
Central square 3 (C3)
Margarida Gaspar de Matos
Current and future challenges associated with emerging cannabis markets
10:50
to
12:20
Main stage
Rosalie Pacula,
Beau Kilmer,
Tom Decorte,
Rosario Queirolo,
Chris Wilkins,
Simon Lenton
Drug treatment
10:50
to
12:20
Knowledge market 3 (K3)
Alison Ritter
Emerging changes in Europe's cannabis situation: policy preparedness and responses to a dynamic situation
10:50
to
12:20
Knowledge market 4 (K4)
Jane Mounteney
Foetal Alcohol Syndrome: piloting best practices towards FAS/FASD prevention. Results from the FAR SEAS European project
10:50
to
12:20
Central square 1 (C1)
Joan Colom
Gambling Research
10:50
to
12:20
Insights zone 3 (I3)
Luke Clark
Gaming and gambling: Characteristics, harms, correlates, and treatment
10:50
to
12:20
Networking zone 2 (N2)
Carla Andrade,
Ita Condron
Getting your addiction research published
10:50
to
12:20
Central square 4 (C4)
Richard Pates
Improving knowledge, taking action
10:50
to
12:20
Networking zone 1 (N1)
Eilish Gilvarry
Prescription opioids and overdose deaths
10:50
to
12:20
Knowledge market 1 (K1)
Thomas Clausen
Reaching out
10:50
to
12:20
Networking zone 4 (N4)
Andrew M Bennett
Substance use, mental health and mental well-being: observations, interventions and recovery promotion
10:50
to
12:20
Networking zone 3 (N3)
Julia Sinclair
Substance-induced psychosis: register-linkage research in Nordic countries
10:50
to
12:20
Knowledge market 2 (K2)
Solja Niemelä
12:20
WHO lunch-time session
Alcohol: at the intersection of policy and science
12:20
to
13:10
Insights zone 4 (I4)
Manuel Cardoso,
Vladimir Poznyak
UNODC-WHO lunch-time session
Designing focused, tailored and prioritized HIV and viral hepatitis interventions for people who use drugs
12:20
to
13:10
Insights zone 3 (I3)
Andrej Kastelic
Lunch break
12:20
to
13:20
13:20
Assessing the impact of laws and policies regulating illicit drugs on health and society: some insights
13:20
to
14:50
Knowledge market 4 (K4)
Peter H. Reuter
Cannabis
13:20
to
14:50
Networking zone 2 (N2)
Myfanwy Graham
Cultures of prevention: training the workforce
13:20
to
14:50
Main stage
Gregor Burkhart
Drug problems, perspectives and patterns of use
13:20
to
14:50
Networking zone 4 (N4)
Paul Dargan
Drug use in diverse communities and settings
13:20
to
14:50
Networking zone 1 (N1)
Ana Neto,
Jochen Schrooten
e-/m-health interventions for substance use disorders
13:20
to
14:50
Central square 3 (C3)
Peter J. Adams
Gambling epidemiology and new trends
13:20
to
14:50
Insights zone 3 (I3)
Elisa Benedetti,
Annie-claude Savard
Global digital addiction interventions: adaptations to target audiences and effectiveness
13:20
to
14:50
Insights zone 2 (I2)
Matthijs Blankers
Hepatitis C epidemiology and prevention
13:20
to
14:50
Knowledge market 3 (K3)
Stine Hoj
Migration, substance use and interventions in Europe
13:20
to
14:50
Insights zone 4 (I4)
Charlotte De Kock,
Klaudia Palczak
Policies for regulating cannabis supply in Europe and the US: the need for appropriate monitoring and evaluation
13:20
to
14:50
Knowledge market 1 (K1)
Liesbeth Vandam
Precision Medicine and Novel Approaches to the Treatment Alcohol Use Disorder
13:20
to
14:50
Central square 1 (C1)
Katie Witkiewitz
Prevention and control of infectious diseases among people who inject drugs: New evidence within the updated guidance from the ECDC and the EMCDDA
13:20
to
14:50
Networking zone 3 (N3)
Janelle Sandberg,
Thomas Seyler
Special at-risk populations and need for diversified interventions to prevent overdoses: insights from the US and Europe, on fentanyl, suicidal overdoses and deaths among teen-agers
13:20
to
14:50
Central square 4 (C4)
Isabelle Giraudon,
Thomas Clausen
The future for Digital Addictions Services. An update from the DigitAS-DADE Project
13:20
to
14:50
Central square 2 (C2)
Marica Ferri
14:50
Break
14:50
to
15:00
15:00
Alcohol use and AUD during COVID-19 pandemic
15:00
to
16:30
Central square 1 (C1)
Benjamin Rolland
Convergence in behavioural addictions
15:00
to
16:30
Main stage
Zsolt Demetrovics
Drug Early Warning Systems – the key to preparedness and response to new psychoactive substances
15:00
to
16:30
Central square 2 (C2)
Ana Gallegos,
Roumen Sedefov
Estimating harm
15:00
to
16:30
Central square 3 (C3)
Xavier Majó Roca
Estimating prevalence
15:00
to
16:30
Knowledge market 4 (K4)
Catherine Comiskey
How prepared are monitoring systems to respond to rapidly changing drug markets in regions bordering the European Union?
15:00
to
16:30
Insights zone 4 (I4)
Ilze Jekabsone,
Frédéric Denecker
Implementation of quality standards in drug demand reduction – where we are and where we are going?
15:00
to
16:30
Knowledge market 1 (K1)
Wouter Vanderplasschen
INDRA: dialogues for an international didactic repository for addictions
15:00
to
16:30
Insights zone 2 (I2)
Marica Ferri
Injecting-related infections and drug surveillance
15:00
to
16:30
Knowledge market 3 (K3)
Adelina Artenie
Scenario Engagement Workshop
15:00
to
16:30
Central square 4 (C4)
Jessica Prendergast,
Clara Jöster-Morisse,
Eva Trier
Short communications on alcohol: Covid, Ketamine, Cognition, Consumption
15:00
to
16:30
Networking zone 3 (N3)
Cristina Ribeiro
Spillover effects of drug policy and why better data are needed
15:00
to
16:30
Networking zone 1 (N1)
Beau Kilmer
Substance use and mental health disorders in Europe: prevalence, models of care, and implementation in a challenging COVID-19 context
15:00
to
16:30
Knowledge market 2 (K2)
Linda Montanari
Surveillance
15:00
to
16:30
Networking zone 4 (N4)
João Matias,
Joanna Stefaniuk
InterGLAM video session
The breadth of global addiction experiences
15:00
to
16:30
Insights zone 1 (I1)
Irena Molnar,
Fleur Braddick
Towards endemicity: A global perspective of the many variants of drug consumption rooms and service models in operation
15:00
to
16:30
Insights zone 3 (I3)
Amanda Roxburgh
Understanding relationships between substance use, mental health and mental illness: Session 1
15:00
to
16:30
Networking zone 2 (N2)
Catriona Matheson
16:30
Coffee break
16:30
to
16:50
16:50
Addiction and comorbidity over the lifespan: mechanisms and interventions
16:50
to
18:20
Central square 2 (C2)
Anna Goudriaan
Alcohol use disorder treatment and its epidemiology
16:50
to
18:20
Central square 1 (C1)
Karl Mann
Assessment of drug policies in light of Sustainable Development Goals and human rights
16:50
to
18:20
Knowledge market 1 (K1)
Eliza Kurcevič
Driving under the influence of cannabis (DUIC)
16:50
to
18:20
Insights zone 3 (I3)
Jan Ramaekers
Drugs and community
16:50
to
18:20
Insights zone 2 (I2)
Rachele Donini
Economic recessions, COVID-19, socio-determinants of drug use and its harms: deaths of despair?
16:50
to
18:20
Central square 4 (C4)
Liesbeth Vandam
EU4MD Treatment facility survey
16:50
to
18:20
Networking zone 2 (N2)
Viktor Mravcik,
Anne Bergenstrom
Focusing on gender issues
16:50
to
18:20
Central square 3 (C3)
Minerva-Melpomeni Malliori
Hepatitis C prevention and treatment among people who inject drugs: Global progress and future requirements
16:50
to
18:20
Knowledge market 3 (K3)
Jason Grebely,
Judy Chang
Impact and lessons learned in implementing and sustaining Needs-Based Planning models for substance use and mental health services and systems
16:50
to
18:20
Knowledge market 2 (K2)
Brian Rush
Improving knowledge, protecting health
16:50
to
18:20
Networking zone 3 (N3)
Fernando Rodriguez De Fonseca
Improving the health of people who use drugs
16:50
to
18:20
Networking zone 4 (N4)
Magdalena Harris
Scanner - Understanding the dynamics and consequences of new psychoactive substances in a rapidly changing (online) drug market
16:50
to
18:20
Insights zone 4 (I4)
Margot Balcaen
Treatment options for drug users in prisons in Central Asia and Germany
16:50
to
18:20
Networking zone 1 (N1)
Ingo Ilja Michels
Why we need evidence-based approaches for the universal measurement of cannabis: rationale and implications for public health, treatment and research
16:50
to
18:20
Main stage
Valentina Lorenzetti,
Tom Freeman
18:20
Break
18:20
to
18:30
18:30
Psychedelic-assisted treatment for substance use disorders – long overlooked or now overhyped?
18:30
to
19:30
Main stage
Nadine Ezard,
Tomáš Páleníček,
Andrea Jungaberle,
John Marsden,
Gabriella Gobbi
19:30
Welcome cocktail with finger food
19:30
to
21:30
NETWORKING ZONE